Home/Healthcare/Biotechnology/Global Biologics Market

Global Biologics Market Size, Share, Opportunities, And Trends By Product Type (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Gene Therapy, Cellular-Based Biologics, Others), By Application (Oncology, Neurology, Cardiology, Hematology, Autoimmune Diseases, Infectious Diseases, Others), And By Geography - Forecasts From 2024 To 2029

$3,950
Single User License
Report OverviewTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

πŸ“ž

Your data is secure. We do not share information with any third party.

Global Biologics Market Report

Report IDKSI061611837
PublishedApr 2024
Pages121
FormatPDF, Excel, PPT, Dashboard

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Frequently Asked Questions

Biologics Market was valued at US$402.182 billion in the year 2022.

The global biologics market is projected to reach a market size of US$761.139 billion by 2029.

The biologics market is projected to grow at a CAGR of 9.54% over the forecast period.

The biologics market is majorly driven by the rising financial investments from the key market players, the growing burden of chronic diseases such as cancer and autoimmune diseases, and the increased demand for innovative therapies.

The biologics market has been segmented by product type, application, and geography.

Need data specifically for your business?Request Custom Research β†’
Related Reports

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon